Analyst consensus rating

Nautilus Biotechnology Analyst Rating: none

Direct answer

Nautilus Biotechnology's consensus rating is none.

3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $4.00.
Forecast evidence checked November 19, 2026.

Get free Nautilus Biotechnology email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Current price
$2.17
Average price target
$4.00
High price target
$4.00
Low price target
$4.00
Low target gap
+84.3%
Target upside
+84.3%
High target gap
+84.3%
Target range width
0%
Consensus rating
none
Analysts
3
Evidence date
November 19, 2026
Valid through
November 26, 2026

Read the frequently asked questions.

What is the analyst consensus rating for Nautilus Biotechnology?

Nautilus Biotechnology has a verified none consensus. The same dataset has an average price target of $4.00.

How far are Nautilus Biotechnology's low and high targets from the recorded price?

The low target implies +84.3%, while the high target implies +84.3%.

How many analysts are included in Nautilus Biotechnology's consensus?

The verified consensus includes 3 analysts.

How is Nautilus Biotechnology's target upside or downside calculated?

The average target of $4.00 is divided by the recorded price of $2.17, then one is subtracted to produce +84.3%. This does not guarantee a future return.

When was Nautilus Biotechnology's analyst forecast verified?

The data was verified on 2026-11-19. The dataset is valid through 2026-11-26.